SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Duran, A.
Right arrow Articles by Emul, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duran, A.
Right arrow Articles by Emul, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CLOZAPINE
Medline Plus Health Information
*High Risk Pregnancy
*Schizophrenia
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Case Report: Clozapine use in two women with schizophrenia during pregnancy

Alaattin Duran

Department of Psychiatry, Medical School of Cerrahpasa, University of Istanbul, Turkey

M. Mufit Ugur

Department of Psychiatry, Medical School of Cerrahpasa, University of Istanbul, Turkey

Senol Turan

Department of Psychiatry, Medical School of Cerrahpasa, University of Istanbul, Turkey

Murat Emul

Department of Psychiatry, Medical School of Afyon Kocatepe University, Turkey, hmuratemul{at}hotmail.com

Stabilized patients who receive clozapine may wish to have children; but studies on pregnant women receiving clozapine treatment are limited. In this study, we report on clozapine use during pregnancy in two women. The first woman (Case 1) had two deliveries while she was receiving clozapine treatment for schizophrenia. Both her deliveries were term, uncomplicated vaginal deliveries, and the clozapine dose was reduced throughout pregnancy. The second woman (Case 2) developed schizophrenia after her first child was born. She became pregnant after clozapine initiation. She delivered twins by term, uncomplicated vaginal delivery. In our cases, no specific risks for the mothers and their children can be attributed to the use of clozapine. Physicians must be aware of the changes in fertility induced by prolactin-sparing drugs. Mothers who receive clozapine treatment should not be advised to breastfeed their children.

Key Words: clozapine • pregnancy • prolactin • schizophrenia

Journal of Psychopharmacology, Vol. 22, No. 1, 111-113 (2008)
DOI: 10.1177/0269881107079171
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Schizophr BullHome page
S. Gentile
Antipsychotic Therapy During Early and Late Pregnancy. A Systematic Review
Schizophr Bull, September 11, 2008; (2008) sbn107v1.
[Abstract] [Full Text] [PDF]


Advertisement